1. Home
  2. ORLA vs TWST Comparison

ORLA vs TWST Comparison

Compare ORLA & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orla Mining Ltd.

ORLA

Orla Mining Ltd.

HOLD

Current Price

$9.79

Market Cap

4.5B

ML Signal

HOLD

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

HOLD

Current Price

$90.99

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORLA
TWST
Founded
2007
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
5.2B
IPO Year
2016
2018

Fundamental Metrics

Financial Performance
Metric
ORLA
TWST
Price
$9.79
$90.99
Analyst Decision
Strong Buy
Buy
Analyst Count
2
8
Target Price
$21.00
$46.88
AVG Volume (30 Days)
3.3M
2.2M
Earning Date
05-08-2026
05-04-2026
Dividend Yield
0.12%
N/A
EPS Growth
N/A
63.89
EPS
N/A
N/A
Revenue
N/A
$376,572,000.00
Revenue This Year
$63.44
$18.91
Revenue Next Year
N/A
$15.07
P/E Ratio
$107.37
N/A
Revenue Growth
N/A
20.32
52 Week Low
$9.15
$23.30
52 Week High
$21.98
$105.47

Technical Indicators

Market Signals
Indicator
ORLA
TWST
Relative Strength Index (RSI) 40.55 56.55
Support Level $9.62 $42.88
Resistance Level $10.50 $105.47
Average True Range (ATR) 0.41 6.98
MACD 0.10 -1.42
Stochastic Oscillator 46.10 40.43

Price Performance

Historical Comparison
ORLA
TWST

About ORLA Orla Mining Ltd.

Orla Mining Ltd is a mineral exploration company. It is engaged in the acquisition and exploration of mineral properties. The company holds three gold projects: the Camino Rojo gold and silver project in Zacatecas State, the Musselwhite gold mine project located in Ontario and the South Railroad projects in Nevada, USA, and the Cerro Quema gold project in Panama. It conducts business activities in Mexico, Panama, the United States, and Canada.

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Share on Social Networks: